Treatment
Blood samples clinical trials
We’re tracking 700 recruiting studies that include Blood samples, each written for real people, not researchers, below.
Recruiting studies
- NCT06297252Recruiting
Psychiatric disorders in pregnancy: a study at ultrasound
This study looks at how common psychiatric conditions (like depression or anxiety) are during pregnancy. It takes place when you come for your second trimester ultrasound and involves answering a few questions.
BéziersAges 18 years+ - NCT06302933Recruiting
Negative HIV test in children treated early: a study
This study looks at why some HIV-positive children who started treatment early may have a negative HIV antibody test. It uses stored blood samples from children who were in the Pediacam III study to better understand the immune response.
DoualaAges Any age - NCT06317467Recruiting
Anti-C1q antibodies and pregnancy outcomes study
This study looks at a specific antibody (anti-C1q) in pregnant women, including those with normal pregnancies, preeclampsia (high blood pressure and protein in urine after 20 weeks), or autoimmune conditions like lupus or antiphospholipid syndrome. The goal is to understand how this antibody might affect pregnancy and help guide care.
TriesteAges 18 years+ - NCT06324149Recruiting
Frailty and aging conditions in chronic diseases
This study looks at how frailty affects the course of chronic diseases and how chronic diseases affect frailty. It may help understand aging-related conditions better.
MilanAges 18–100 - NCT07633366Recruiting
Understanding ARDS Through Lung Fluid and Imaging Analysis
This study examines lung fluid samples and imaging scans from patients on breathing machines to better understand acute respiratory distress syndrome (ARDS), a serious lung condition. Researchers hope this will help doctors diagnose and treat ARDS more effectively in the future.
Vienna, State of ViennaAges 18 years+ - NCT07570524Recruiting
Predicting Treatment Response in Early Triple-Negative Breast Cancer
This study helps doctors predict which patients will respond best to immunochemotherapy (a combination of immune-boosting and chemotherapy drugs) for early-stage triple-negative breast cancer. By understanding your tumor better before treatment, doctors may be able to personalize your care plan.
RennesAges 18 years+ - NCT06332274RecruitingPhase 3
Tislelizumab for cancer patients with minimal residual disease
This trial is for people who have completed standard cancer treatments (like surgery, chemo or radiation) and have no visible cancer on scans, but may still have very small amounts of cancer DNA in their blood. The study tests whether the drug tislelizumab can help prevent the cancer from coming back.
Villejuif, Val De MarneAges 18 years+ - NCT06344650Recruiting
Understanding bone strength in acromegaly
This study looks at what makes bones strong or weak in people with acromegaly (a condition that causes too much growth hormone). It aims to find better ways to check bone health and prevent fractures.
MilanAges 18 years+ - NCT06355245Recruiting
Early cancer detection study for unexplained symptoms
This study looks for early signs of cancer in people who have unexplained symptoms like extreme tiredness, weight loss, fever, or abnormal lab tests. You will be monitored and tested to see if markers can find cancer sooner.
StockholmAges 18 years+ - NCT06360302Recruiting
Exercise and insulin resistance in dialysis patients
This study looks at how exercise affects muscle metabolism and insulin resistance in people on dialysis, compared to those with metabolic syndrome and healthy individuals. It aims to find blood markers that could help assess insulin resistance in dialysis patients.
MontpellierAges 40–75 - NCT06371976Recruiting
Stress hormone system study after heart surgery
This study looks at how your body's stress hormone system (the HPA axis) works after heart surgery if you develop vasoplegic syndrome (a serious drop in blood pressure). The goal is to understand if giving extra steroids might help. If you are scheduled for heart surgery with a heart-lung machine, you may be able to join.
Paris, Île-de-France RegionAges 18 years+ - NCT06387017Recruiting
Can blood tests improve lung cancer screening in smokers with artery disease?
This study looks at whether certain blood tests can help find lung cancer early in people who have smoked for a long time and also have artery disease. The goal is to see if adding these tests to current screening methods can better identify those at highest risk.
MarseilleAges 45–80 - NCT06399666Recruiting
Inflammation markers and genes in atrial fibrillation prediction
This trial looks at whether certain blood markers and genetic information can help predict atrial fibrillation (irregular heartbeat). It studies how inflammation might play a role, and aims to find better ways to identify people at risk.
Jönköping, SmålandAges 18 years+ - NCT06408701Recruiting
Lab-grown eye cells from people with eye problems
This study uses stem cells from people with eye malformations to grow tiny 3D eye organ-like structures in the lab. The goal is to better understand how eye problems develop, which could lead to new treatments in the future.
Clermont-FerrandAges 6 years+ - NCT06425133RecruitingPhase 2
Regorafenib plus low-dose chemo for advanced colorectal cancer
This trial tests a combination of regorafenib (a targeted pill that cuts off blood supply to tumors) with a low-dose, continuous chemotherapy regimen for people whose colorectal cancer has spread and is no longer responding to standard treatments. The goal is to see if this mix can slow or stop the cancer's growth.
AuxerreAges 18 years+ - NCT06430021Recruiting
Blood test for neuroendocrine tumors in MEN1
This study is testing a new blood test to see if it can help diagnose neuroendocrine tumors in people with MEN1, a genetic condition that increases the risk of these tumors. The test looks for a protein called hPG80 (progastrin) and may help doctors find tumors earlier.
DijonAges 18–60 - NCT06434207Recruiting
Heart defect study in newborns to understand blood clots
This study looks at tiny particles from cells in newborns with heart defects to understand blood clot risks. It aims to find ways to prevent clots after heart surgery.
Boston, MassachusettsAges 1 day–1 week - NCT06439940Recruiting
Early breast cancer detection with blood test
This study tests a new blood test (liquid biopsy) that looks for tiny molecules called microRNAs to find early signs of breast cancer. It aims to detect cancer before symptoms appear, using a simple blood draw during your regular mammogram visit.
El Palomar, Morón, Buenos AiresAges 35 years+ - NCT06441123Recruiting
A trial of a new HIV latency-reversing drug
This trial tests a new type of medicine that aims to wake up HIV hiding in your body's cells by targeting a viral protein called Tat. The goal is to help find a way to clear the virus completely.
MontpellierAges 18 years+ - NCT06442592Recruiting
Understanding development in kids with heart defects
This study looks at how children with complex congenital heart defects develop, especially their brain and learning skills. It will help doctors provide better support for these children.
Brest, Brittany RegionAges 3–11 - NCT06444646Recruiting
Studying fat cell particles in obesity
This study looks at tiny particles released from fat tissue in people with and without obesity. It aims to understand differences that might help explain obesity-related health problems.
Genk, LimburgAges 18–65 - NCT06446947Recruiting
Blood markers for poor outcomes after sepsis in cancer surgery
This study looks at blood markers (epigenetics) to better understand why some people have a harder time recovering from a severe infection after major cancer surgery. The goal is to find early signs of poor outcomes in men aged 45–75 with post-surgery sepsis.
Marseille, Bouches du RhôneAges 45–75 - NCT06451744Recruiting
Study of biomarkers in lichen planus
This study looks at people with lichen planus (a rash that can affect skin, mouth, or genitals) to find markers in cells and blood that may help understand the disease. If you have a new diagnosis or a flare-up, and you are not on strong immune-suppressing medicine, you may be able to join.
BesançonAges 18 years+ - NCT06462768Recruiting
Study of immune cell activity in systemic sclerosis
This study looks at a specific type of immune cell activity (called neutrophil extracellular traps) in the blood of people with systemic sclerosis, other connective tissue diseases, and healthy volunteers. It aims to understand how these cells may be involved in the disease and could lead to better treatments.
ReimsAges 18 years+
Common questions
- Are there clinical trials studying Blood samples?
- Yes. Clin2 currently lists 700 recruiting studies that include Blood samples, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Blood samples trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Blood samples an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Blood samples or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.